NCT03697460View on ClinicalTrials.gov

Topical Ruxolitinib Lichen Planus

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

June 25, 2020

Study Completion Date

August 25, 2020

Conditions
Lichen Planus
Interventions
DRUG

INCB018424

INCB018424 PHOSPHATE CREAM 1.5%, topical application, twice daily on lesions of cutaneous LP.

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

All Listed Sponsors
lead

Aaron R. Mangold

OTHER

NCT03697460 - Topical Ruxolitinib Lichen Planus | Biotech Hunter | Biotech Hunter